| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 560 | $530 | $294.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 3,420 | $60 | $195.1K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 120 | $840 | $104K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 1,760 | $60 | $98.7K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 60 | $1,340 | $83.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,940 | $40 | $71.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 770 | $90 | $69.9K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 1,110 | $20 | $17.8K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 720 | $20 | $10.8K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 200 | $30 | $5.3K |